1998 Fiscal Year Final Research Report Summary
Molecular detection of circulating renal cell carcinoma cells by RT-PCR
| Project/Area Number |
09671643
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Urology
|
|---|
| Research Institution | Nara Medical University |
|---|
Principal Investigator |
UEMURA Hirotsugu Dept.Urol.Nara Med.Univ, Assist.Prof., 医学部, 講師 (90213397)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
YOSHIKAWA Kazuhiro 2nd Dept.Pathol.Aichi Med.Univ, Assist.Prof., 医学部, 講師 (60109759)
HIRAO Yoshihiko Dept.Urol.Nara Med.Univ, Prof., 医学部, 教授 (00133207)
|
|---|
| Project Period (FY) |
1997 – 1998
|
| Keywords | renal cell carcinoma / MN / CA IX / G250 antigen / MN / CA9 / G250 gene / RT-PCR / marker |
|---|
| Research Abstract |
A murine monoclonal antibody G250 (MAbG25O) raised against human renal cell carcinoma (RCC)(Oosterwijk, et al, 1986) has been known to react with a large proportion of RCC, but not with the norma1 kidney tissue. The antigen recognized by MAbG25O is present in the plasma membrane and expresses in several types of malignancies. Recently, G250 antigen gene has been isolated (Oosterwijk et al. 1995), and database analysis revealed that G250 antigen is identical to MN/CA IX originally deribed from Hela cell (Pastorek et al, 1994). To determine whether G250 antigen (MN/CA IX/G250) could be a potential therapeutic target and a tumor marker, a total of 147 cases of RCC were investigated immunohistochemically as well as, by reverse transcriptase polymerase chain reaction (RT-PCR) anilysis. In addition, total RNAs extracted from patients' peripheral blood samples were analyzed for MN/CA9/G250 mRNA signals. Immunohistochenistry resulted in strong expression in 128/147 (87.1%) of RCC, in contrast to the lack of expression observed in normal tissues. RT-PCR analyses of frozen specimens resulted in the clear detection of MN/CA9/G25OmRNA signals in 137/147 (93.2 %), and despite of the subtle differences, the results were almost identical to those for immunohistochemistry. Although high grade and stage tumors exhibited significaitly lower expression than low grade and stage tumors, a large proportion of tumors expressed MN/CA9 IX/G250 protein as well as mRNA.RT-PCR analysis of patients' blood samples revealed the presence of circulating MN/CA9/G25O expressing cells. These findings suggest that this antigen may be a potential therapeutic target as well as diagnostic marker for RCCs.
|
Research Products
(12 results)
-
-
-
-
-
-
-
-
[Publications] Uemura, H., Nakagawa, Y., Ozono, S., Hirao, Y., Okajima, E.and Yoshikawa, K: "MN targeting immunotherapy for renal cell carcinoma." Biotherapy. 12. 884 (1999)
Description
「研究成果報告書概要(欧文)」より
-
-
[Publications] Cho, M., Konishi, N., Kitahori, Y., Hiasa, Y., Nakagawa, Y., Uemura, H., Hirao, Y.and Oosterwijk, E: "Detection of DNA amplification in human renal cell carcinoma cell lines using restriction landmark genomic scanning." Cell.mol.Biol.44. 913-918 (1998)
Description
「研究成果報告書概要(欧文)」より
-
[Publications] Cho, M., Konishi, N., Yamamoto, K., Inui, T., Kitahori, Y., Nakagawa, Y., Uemura, H., Hirao, Y.and Hiasa, Y: "Genomic aberrations in renal cell carcinomas detected by restriction landmark genomic scanning." European Journal of Cancer. 13. 2112-2118 (1998)
Description
「研究成果報告書概要(欧文)」より
-
[Publications] Nakagawa, Y., Uemura, H., Hirao, Y., Yoshida, K., Saga, S and Yoshikawa, K: "Radiation hybrid mapping of the human MN/CA9 locus to chromosame band 9p12-p13." Genomics. 53. 118-119 (1998)
Description
「研究成果報告書概要(欧文)」より
